Q4 2025 Femtech Funding Roundup: Record Deals and Emerging Trends
From AI-powered fertility platforms to personalized hormone therapy apps—we break down the quarter's most significant raises and what they signal for the sector.
From AI-powered fertility platforms to personalized hormone therapy apps—we break down the quarter's most significant raises and what they signal for the sector.
The femtech market has matured far beyond its early focus on menstrual health. We explore the next wave of innovation reshaping women's healthcare.
Femtech companies consistently outperform market benchmarks, yet remain chronically underfunded. The data makes a compelling case for portfolio diversification.
Polycystic ovary syndrome affects 10% of women globally. We compare the leading digital solutions vying for market share.
What separates promising femtech ventures from overhyped pitches? Our checklist for evaluating early-stage opportunities.
From AI-powered fertility platforms to personalized hormone therapy apps—we break down the quarter's most significant raises and what they signal for the sector.
From AI-powered fertility platforms to personalized hormone therapy apps—we break down the quarter's most significant raises and what they signal for the sector.